Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Dapeng Pharm & Chem is a Chinese manufacturing company focused on fine chemicals and pharmaceutical/chemical intermediates rather than innovative therapeutics. The company is best known as a producer of xylidine-series aromatic amines, including 2,4-xylidine, 2,6-xylidine, 2,3-xylidine, and related specialty chemicals used in downstream industrial and pharmaceutical synthesis. Publicly available company profiles describe it as established in 1997, with a major plant build-out in Wuqiao, Hebei, and certifications including ISO 9001, ISO 14001, and OHSAS 18001. Its business appears to center on process manufacturing, scale-up, and export supply of fine chemical raw materials and intermediates rather than clinical drug development. Based on available evidence, it should be categorized as a commercial specialty chemical and pharma-chemical intermediate supplier with manufacturing capabilities in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Dapeng Pharm & Chem.